Ongoing research is focused on understanding the mechanisms by which BRCA2 mutations lead to cancer and developing new targeted therapies. Clinical trials are continually evaluating the efficacy and safety of new drugs and treatment combinations. Research is also being conducted to refine genetic testing methods and identify additional genetic and environmental factors that may influence cancer risk in BRCA2 mutation carriers.
